Combinations Alliance EOI Calls - AstraZeneca
AstraZeneca Expression of Interest Call - open until 25th June, 2014
We are delighted to announce our next Joint Expression of Interest (EOI) call with the ECMC Combinations Alliance, AstraZeneca and the NIHR CRN: Cancer Alliance.
Webexes were held on 14th and 21st May respectively covering the 13 compounds on offer. These confidential presentations can be obtained from Graham Fisher at AstraZeneca.
We welcome early phase proposals with radiotherapy, chemotherapy or other novel compound combinations. EOIs that are clinic ready, require access to an additional compound for the proposed combination or additional preclinical evidence are invited to be submitted on the EOI template to the Combinations Alliance mailbox by the 25th June 2014. EOIs that are of interest to the Combinations Alliance and AZ will be invited to prepare and present a standard presentation at a Joint workshop to be held in London on 12th-13th November, 2014.
Summary of Key Dates
| Return date for EOIs using the attached EOI template | 25 Jun 2014 |
| Preliminary project selection communicated | 6 Aug 2014 |
| Return date for presentations | 15 Oct 2014 |
| Project review workshop | 12-13 Nov 2014 |
| Final project selection communicated | early Dec 2014 |
| NAC closing date | 4 Apr 2014 |
| NAC meeting | 17 Jun 2015 |